LIVE EVENT: The U.S. healthcare law rollout: Where do we stand?
ORLANDO, Florida - A Florida researcher is preparing to test massive dust storms in the upper atmosphere that roll in from Africa to see whether pathogens raining down on the state could be responsible for plant, animal or human disease.
FAYETTEVILLE, North Carolina - Water pollution at the Camp Lejeune military base in North Carolina has been linked to increased risk of birth defects and childhood cancers, according to the U.S. Centers for Disease Control and Prevention.
MEXICO CITY - Six men suspected of stealing a dangerous radioactive cargo from a truck outside Mexico City earlier this week have been treated in a hospital for signs of radiation exposure and remain under police guard, officials said on Friday.
- U.S. health regulators on Friday approved Auxilium Pharmaceuticals Inc's Xiaflex injections to treat a condition that causes a painful curvature of the penis called Peyronie's disease.
- U.S. regulators on Friday approved Gilead Sciences Inc's Sovaldi as a potentially easier cure for chronic infection with the liver-destroying hepatitis C virus.
BASEL - Fifteen years ago Ian Parkhill was diagnosed with a rare muscle-wasting disease that gradually robbed him of the strength in his thighs.
- GlaxoSmithKline and Theravance Inc said on Friday that their combination therapy met the main goal of improving lung function in asthma patients in a late-stage trial.
New York (Reuters Health) - The gold standard for treating childhood obesity currently involves using a family-based approach in which both parents and children attend meetings on losing weight. A new review of past studies suggests parent-only meetings may work just as well.
NEW YORK (Reuters Health) - Three different strategies to reduce the amount of time people spend sitting at work seemed effective, in a new study. But in jobs without flexible schedules, they only reduced sitting time by about eight minutes per day.
ZURICH - An experimental drug from Novartis to treat a type of bone marrow cancer met its primary goal in a late-stage study, the Swiss drugmaker said on Friday.
On Wednesday, December 4 at 10:30 a.m. watch live as experts assess where the U.S. stands in the healthcare law rollout and the resulting health policy implications. Presented by the forum at Harvard School of Public Health in collaboration with Reuters. Live Coverage